Skip to main content
Elsevier

PET Imaging in the Management of Neuroendocrine Tumors, An Issue of PET Clinics

  • 1st Edition, Volume 9-1 - December 2, 2013
  • Latest edition
  • Authors: Stefano Fanti, Cristina Nanni, Richard P. Baum
  • Language: English

Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of… Read more

Purchase options

Info / Buy

Description

Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F-DOPA, Ga-DOTA-peptides, Yttrium- and Lutetium-based therapy, and the role of FDG PET. It also covers key information of theranostics.

Product details

  • Edition: 1
  • Latest edition
  • Volume: 9-1
  • Published: December 2, 2013
  • Language: English

About the authors

SF

Stefano Fanti

Affiliations and expertise
Intitute of Nuclear Medicine, University of Bologna, Italy

CN

Cristina Nanni

Affiliations and expertise
Nuclear Medicine Department, Intitute of Nuclear Medicine, University of Bologna, Italy

RB

Richard P. Baum

Affiliations and expertise
Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Germany